TEMPUS Introduction
Tempus is a leading AI-enabled precision medicine technology company that combines clinical and molecular data with advanced machine learning to deliver personalized healthcare solutions for cancer and other diseases.
View MoreWhat is TEMPUS
Founded in 2015 in Chicago by Eric Lefkofsky, Tempus is a healthcare technology company that has built the world's largest library of clinical and molecular data to make precision medicine a reality. The company uses artificial intelligence and machine learning to analyze this massive collection of data to help physicians make more data-driven treatment decisions, assist pharmaceutical companies in drug development, and help patients find optimal therapies. Tempus operates across multiple disease areas including oncology, cardiology, psychiatry, and infectious diseases, with a particular focus on cancer care.
How does TEMPUS work?
Tempus works by collecting and analyzing both clinical and molecular data through various platforms and tools. Their comprehensive testing services include genomic sequencing, clinical trial matching, and algorithmic testing. The company's AI platform processes this data to generate actionable insights that can be accessed through products like Tempus One (an AI clinical assistant), Tempus Hub (a provider portal), and various other specialized solutions. For pharmaceutical companies, Tempus provides services like real-world data analysis, clinical trial optimization, and companion diagnostics development. The company also offers patient-facing solutions like the olivia app to help patients manage their health data and find clinical trials.
Benefits of TEMPUS
The key benefits of Tempus include enabling more personalized and effective treatment decisions through data-driven insights, accelerating drug development through better patient identification and trial matching, and improving patient outcomes through early disease detection and optimal therapy selection. For healthcare providers, it offers streamlined workflows and access to comprehensive molecular and clinical data. For pharmaceutical companies, it provides valuable real-world data and accelerates drug development. For patients, it offers better access to clinical trials and personalized treatment options. The platform has demonstrated success in identifying targeted therapies and clinical trials for a large proportion of cancer patients, with connections to over 50% of oncologists in the US and partnerships with 95% of the top 20 pharmaceutical oncology companies.
TEMPUS Monthly Traffic Trends
TEMPUS experienced a slight 9.1% decline in traffic with 148,803 visits in the recent month. Despite significant financial growth and strategic acquisitions, the slight decline in visits might reflect normal market fluctuations or seasonal variations.
View history traffic
Popular Articles

Gentube Review 2025: Fast, Free, and Beginner-Friendly AI Image Generator
Jun 16, 2025

SweetAI Chat vs Girlfriendly AI: Why SweetAI Chat Is the Better Choice in 2025
Jun 10, 2025

SweetAI Chat vs Candy.ai 2025: Find Your Best NSFW AI Girlfriend Chatbot
Jun 10, 2025

How to Use GitHub in 2025: The Ultimate Beginner’s Guide to Free AI Tools, Software, and Resources
Jun 10, 2025
View More